Covid-19: UK will roll out Moderna's omicron BA.1 vaccine as part of autumn booster programme

被引:3
|
作者
Mahase, Elisabeth
机构
来源
关键词
D O I
10.1136/bmj.o2038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Is a booster dose of COVID-19 vaccines effective on newly dominant omicron subvariants among university students? Comparison between BA.1 and BA.2 dominancy
    Miyauchi, Shunsuke
    Hiyama, Toru
    Nakano, Yukiko
    Yoshino, Atsuo
    Miyake, Yoshie
    Okamoto, Yuri
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2023, 51 (08) : 907 - 911
  • [22] Covid-19: Deadline for roll out of UK's tracing app will be missed
    Armstrong, Stephen
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 369 : m2085
  • [23] Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign
    Shawe-Taylor, Marianne
    Greenwood, David
    Hobbs, Agnieszka
    Dowgier, Giulia
    Penn, Rebecca
    Sanderson, Theo
    Stevenson-Leggett, Phoebe
    Bazire, James
    Harvey, Ruth
    Libri, Vincenzo
    Kassiotis, George
    Gamblin, Steve
    Lewis, Nicola S.
    Williams, Bryan
    Swanton, Charles
    Gandhi, Sonia
    Carr, Edward J.
    Wu, Mary Y.
    Bauer, David L., V
    Wall, Emma C.
    [J]. LANCET, 2024, 403 (10432): : 1133 - 1136
  • [24] COVID-19 Disease Severity in Persons Infected With Omicron BA.1 and BA.2 Sublineages and Association With Vaccination Status
    Butt, Adeel A.
    Dargham, Soha R.
    Coyle, Peter
    Yassine, Hadi M.
    Al-Khal, Abdullatif
    Abou-Samra, Abdul-Badi
    Abu-Raddad, Laith J.
    [J]. JAMA INTERNAL MEDICINE, 2022, 182 (10) : 1097 - 1099
  • [25] Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO)
    Tuan, Jessica J.
    Sharma, Manas
    Kayani, Jehanzeb
    Davis, Matthew W.
    McManus, Dayna
    Topal, Jeffrey E.
    Ogbuagu, Onyema
    [J]. BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [26] Risk Factors Related to COVID-19 Reinfection and Fatality During the Omicron (BA.1/BA. 2) Period in Korea
    Lee, Ju Hee
    Hwang, Ji Hae
    Jang, Eun Jung
    Kim, Ryu Kyung
    Lee, Kil Hun
    Park, Seon Kyeong
    Gwack, Jin
    Park, Young Joon
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (34)
  • [27] COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era
    Hedvat, Jessica
    Lange, Nicholas W.
    Salerno, David M.
    DeFilippis, Ersilia M.
    Kovac, Danielle
    Corbo, Heather
    Chen, Justin K.
    Choe, Jason Y.
    Lee, Jennifer H.
    Anamisis, Anastasia
    Jennings, Douglas L.
    Codispodo, Giovanna
    Shertel, Tara
    Brown, Robert S., Jr.
    Pereira, Marcus R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (11) : 2682 - 2688
  • [28] Delayed COVID-19 vaccine roll-out in Japan
    Kosaka, Makoto
    Hashimoto, Takanao
    Ozaki, Akihiko
    Tanimoto, Tetsuya
    Kami, Masahiro
    [J]. LANCET, 2021, 397 (10292): : 2334 - 2335
  • [29] Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5
    Kawasuji, Hitoshi
    Morinaga, Yoshitomo
    Tani, Hideki
    Saga, Yumiko
    Yamada, Hiroshi
    Yoshida, Yoshihiro
    Takegoshi, Yusuke
    Kaneda, Makito
    Murai, Yushi
    Kimoto, Kou
    Ueno, Akitoshi
    Miyajima, Yuki
    Nagaoka, Kentaro
    Ono, Chikako
    Matsuura, Yoshiharu
    Niimi, Hideki
    Yamamoto, Yoshihiro
    [J]. MICROBIOLOGY SPECTRUM, 2023, 11 (02):
  • [30] Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO)
    Jessica J. Tuan
    Manas Sharma
    Jehanzeb Kayani
    Matthew W. Davis
    Dayna McManus
    Jeffrey E. Topal
    Onyema Ogbuagu
    [J]. BMC Infectious Diseases, 23